Viva Biotech's Wholly-Owned Subsidiary Langhua Pharmaceutical Successfully Passes U.S. FDA On-Site Inspection

Viva Biotech's Wholly-Owned Subsidiary Langhua Pharmaceutical Successfully Passes U.S. FDA On-Site Inspection

SHANGHAI, March 28, 2025 /PRNewswire/ -- Zhejiang Langhua Pharmaceutical Co., Ltd. ("Langhua Pharmaceutical"), a wholly-owned subsidiary of Viva Biotech Holdings ("Viva Biotech"), underwent a cGMP (Current Good Manufacturing Practices) on-site...

Bloomage Passes GMP Audit by South Korea's MFDS, Strengthening its Global Quality Assurance

Bloomage Passes GMP Audit by South Korea's MFDS, Strengthening its Global Quality Assurance

PARSIPPANY, NJ., March 18, 2025 /PRNewswire/ -- Bloomage, a global leader in hyaluronic acid and other bioactive substance innovations, has successfully passed the GMP on-site inspection by South Korea's Ministry of Food and Drug Safety (MFDS) with...

IHS Passes Rigorous Audit for World-Wide Distribution of its Insignis™ Infusion System

IHS Passes Rigorous Audit for World-Wide Distribution of its Insignis™ Infusion System

Innovative Health Sciences has successfully secured the exclusive Medical Device Regulations Quality Management System Certificate from BSI (CE MDR QMS), a leading notified body, thus facilitating the introduction of the Insignis™ Infusion System...

menu
menu